Neurocrine Biosciences, Inc. NBIX
164.63 USD +4.87 (+3.05%)
At closeNov 6, 2026, 4:27 PM EST
164.63 0.00 0.00%
After hours · Nov 6, 4:27 PM ET
158.66 Day range 165.86
122.14 52-week range 186.12
- YTD
- +16.08%
- 1 year
- +6.35%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 713.00M | 233.00M | 251.10M | 262.90M | 340.80M | |
| 713.00M | 233.00M | 251.10M | 262.90M | 340.80M | |
| 1.95B | 1.71B | 1.63B | 1.13B | 994.90M | |
| 767.40M | 843.10M | 780.50M | 726.40M | 370.50M | |
| 1.18B | 864.30M | 849.40M | 401.50M | 624.40M | |
| 686.80M | 479.10M | 439.30M | 350.00M | 185.50M | |
| 2.52B | 1.72B | 1.61B | 1.45B | 972.80M | |
| 545.20M | 592.00M | 347.30M | 145.60M | 155.80M | |
| 4.63B | 3.72B | 3.25B | 2.37B | 2.07B | |
| 415.30M | 455.10M | 428.40M | 262.90M | 440.40M | |
| 743.40M | 507.70M | 654.80M | 537.70M | 245.80M | |
| 415.30M | 455.10M | 258.30M | 93.50M | 440.40M | |
| 1.38B | 1.13B | 1.02B | 660.90M | 698.50M | |
| 447.70M | 29.20M | -157.10M | -406.80M | -635.80M | |
| 13.10M | 5.80M | 7.00M | -7.90M | -1.70M | |
| 3.25B | 2.59B | 2.23B | 1.71B | 1.37B | |
| 3.25B | 2.59B | 2.23B | 1.71B | 1.37B | |
| 2.11B | 1.99B | 1.64B | 915.20M | 1.10B | |
| 415.30M | 455.10M | 428.40M | 262.90M | 440.40M | |
| 10.80M | 0 | 35.50M | 37.20M | 0 | |
| 69.00M | 57.40M | 38.30M | 35.10M | 30.50M | |
| 635.00M | 621.30M | 364.60M | 123.20M | 452.70M | |
| 674.30M | 461.60M | 448.80M | 347.60M | 225.80M | |
| 320.30M | 485.70M | 362.60M | 305.90M | 315.10M |